Dockets Entered on January 1, 2007

Dockets Management



Dockets Entered On February 28, 2007



Docket #	Title

1997S-0162	30-Day Structure Function Claim Notification Letters Dietary

2003N-0573	Draft Animal Cloning Risk Assessment

2004D-0193	Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)

2006D-0480	Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration

2006N-0425	Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notification

2006P-0498	Use of symbols on the principal display panel that would communicate to consumers the healthfulness of foods

2007D-0021	Guidance for Industry; Advisory Committee Meetings: Preparation and Public Availability of Information Given to Advisory Committee Members

2007N-0016	Sentinel Network To Promote Medical Product Safety

2007N-0019	Medical Devices; Anesthesiology Devices; Oxygen Pressure Regulators and Oxygen Conserving Devices

1997S-0162	30-Day Structure Function Claim Notification Letters Dietary

LET 19008	PuraPharm Corporation	Vol #:	171

LET 19009	PuraPharm Corporation	Vol #:	171

LET 19010	PuraPharm Corporation	Vol #:	171

LET 19011	PuraPharm Corporation	Vol #:	171

LET 19012	PuraPharm Corporation	Vol #:	171

LET 19013	PuraPharm Corporation	Vol #:	171

LET 19014	PuraPharm Corporation	Vol #:	171

LET 19015	PuraPharm Corporation	Vol #:	171

LET 19016	PuraPharm Corporation	Vol #:	171

LET 19017	PuraPharm Corporation	Vol #:	171

LET 19018	PuraPharm Corporation	Vol #:	171

LET 19019	PuraPharm Corporation	Vol #:	171

LET 19020	PuraPharm Corporation	Vol #:	171

LET 19021	PuraPharm Corporation	Vol #:	171

LET 19022	PuraPharm Corporation	Vol #:	171

LET 19023	PuraPharm Corporation	Vol #:	171

LET 19024	PuraPharm Corporation	Vol #:	171

LET 19025	PuraPharm Corporation	Vol #:	171

LET 19026	PuraPharm Corporation	Vol #:	171

LET 19027	PuraPharm Corporation	Vol #:	171

LET 19028	PuraPharm Corporation	Vol #:	171

LET 19029	PuraPharm Corporation	Vol #:	171

LET 19030	PuraPharm Corporation	Vol #:	171

LET 19031	PuraPharm Corporation	Vol #:	171

LET 19032	PuraPharm Corporation	Vol #:	171



LET 19033	PuraPharm Corporation	Vol #:	171

LET 19034	PuraPharm Corporation	Vol #:	171

LET 19035	PuraPharm Corporation	Vol #:	171

LET 19036	PuraPharm Corporation	Vol #:	171

LET 19037	PuraPharm Corporation	Vol #:	171

LET 19038	PuraPharm Corporation	Vol #:	171

LET 19039	PuraPharm Corporation	Vol #:	171

LET 19040	PuraPharm Corporation	Vol #:	171

LET 19041	PuraPharm Corporation	Vol #:	171

LET 19042	PuraPharm Corporation	Vol #:	171

LET 19043	PuraPharm Corporation	Vol #:	171

LET 19044	PuraPharm Corporation	Vol #:	171

LET 19045	PuraPharm Corporation	Vol #:	171

LET 19046	PuraPharm Corporation	Vol #:	171

LET 19047	PuraPharm Corporation	Vol #:	171

LET 19048	PuraPharm Corporation	Vol #:	171

LET 19049	PuraPharm Corporation	Vol #:	171

LET 19050	PuraPharm Corporation	Vol #:	171

LET 19051	PuraPharm Corporation	Vol #:	171

LET 19052	PuraPharm Corporation	Vol #:	171

LET 19053	PuraPharm Corporation	Vol #:	171

LET 19054	PuraPharm Corporation	Vol #:	171

LET 19055	PuraPharm Corporation	Vol #:	171

LET 19056	PuraPharm Corporation	Vol #:	171

LET 19057	PuraPharm Corporation	Vol #:	171

LET 19058	PuraPharm Corporation	Vol #:	171

LET 19059	PuraPharm Corporation	Vol #:	171

LET 19060	PuraPharm Corporation	Vol #:	171

LET 19061	PuraPharm Corporation	Vol #:	171

LET 19062	PuraPharm Corporation	Vol #:	171

LET 19063	PuraPharm Corporation	Vol #:	171

LET 19064	PuraPharm Corporation	Vol #:	171

LET 19065	PuraPharm Corporation	Vol #:	171

LET 19066	PuraPharm Corporation	Vol #:	171

LET 19067	PuraPharm Corporation	Vol #:	171

LET 19068	PuraPharm Corporation	Vol #:	171

LET 19069	PuraPharm Corporation	Vol #:	171



LET 19070	PuraPharm Corporation	Vol #:	171

LET 19071	PuraPharm Corporation	Vol #:	171

LET 19072	PuraPharm Corporation	Vol #:	171

LET 19073	PuraPharm Corporation	Vol #:	171

LET 19074	PuraPharm Corporation	Vol #:	171

LET 19075	PuraPharm Corporation	Vol #:	171

LET 19076	PuraPharm Corporation	Vol #:	171

LET 19077	PuraPharm Corporation	Vol #:	171

LET 19078	PuraPharm Corporation	Vol #:	171

LET 19079	PuraPharm Corporation	Vol #:	171

LET 19080	Global Healing Center, Inc.	Vol #:	171

LET 19081	Meyvita Corporation	Vol #:	171

LET 19082	Perrigo Company of South Carolina	Vol #:	171

LET 19083	Perrigo Company of South Carolina	Vol #:	171

LET 19084	Perrigo Company of South Carolina	Vol #:	171

LET 19085	Perrigo Company of South Carolina	Vol #:	171

LET 19086	Perrigo Company of South Carolina	Vol #:	171

LET 19087	Perrigo Company of South Carolina	Vol #:	171

LET 19088	Perrigo Company of South Carolina	Vol #:	171

LET 19089	Perrigo Company of South Carolina	Vol #:	171

LET 19090	Perrigo Company of South Carolina	Vol #:	171

LET 19091	NBTY Inc.	Vol #:	171

LET 19092	NBTY Inc.	Vol #:	171

LET 19093	NBTY Inc.	Vol #:	171

LET 19094	NBTY Inc.	Vol #:	171

LET 19095	NBTY Inc.	Vol #:	171

LET 19096	McLind Corporation	Vol #:	171

LET 19097	NBTY Inc.	Vol #:	171

2003N-0573	Draft Animal Cloning Risk Assessment

C 225	K. Sims	Vol #:	22

C 226	J. Lesniewski	Vol #:	22

C 227	K. Tussing	Vol #:	22

C 228	W. Desher	Vol #:	22

C 229	S. Ferrell	Vol #:	22

C 230	H. Searle	Vol #:	22

C 231	M. Brandan	Vol #:	22



C 232	B. Frey	Vol #:	22

C 233	K. Baker	Vol #:	22

C 234	C. Schulz	Vol #:	22

C 235	M. Patton	Vol #:	22

C 236	V. Kobylarz	Vol #:	22

C 237	N. Dresher	Vol #:	22

C 238	C. Schurer	Vol #:	22

C 239	P. Joralgmon	Vol #:	22

C 240	D. Davies	Vol #:	22

C 241	A. Hanazomo	Vol #:	22

C 242	L. Martineau	Vol #:	22

C 243	W. Watson	Vol #:	22

C 244	Leslie Langee	Vol #:	22

C 245	C. Thomas	Vol #:	22

C 246	P. Granhame	Vol #:	22

C 247	D.Ohlinger	Vol #:	22

C 248	E. Spaeth	Vol #:	22

C 249	A. Zyla	Vol #:	22

C 250	M. Henshaw	Vol #:	22

C 251	G. Mack	Vol #:	22

C 252	S. Evans	Vol #:	22

C 253	P. Olsen	Vol #:	22

C 254	P. Olsen	Vol #:	22

C 255	E. Stewart	Vol #:	22

C 256	B. Ferreira	Vol #:	22

C 257	P. Shaffer	Vol #:	22

C 258	L. McLaughlin	Vol #:	23

C 259	S. Cockshott	Vol #:	23

C 260	S. Meerman`	Vol #:	22

C 261	N. Conger	Vol #:	23

C 262	K. Nekola	Vol #:	23

C 263	H. Hilker	Vol #:	23

C 264	A. McChesnez	Vol #:	23

C 265	J. Kramer	Vol #:	23

C 266	S. Family	Vol #:	23

C 267	no signature	Vol #:	23

C 268	E. Austin	Vol #:	23



C 269	E. Russell	Vol #:	23

C 270	E. Perkins	Vol #:	23

C 271	A. Carrington	Vol #:	23

C 272	D. Hayward	Vol #:	23

C 273	J. Ellis	Vol #:	23

C 274	R. Westra	Vol #:	23

C 275	D. Ricci	Vol #:	23

EXT 4	M. Green	Vol #:	22

EXT 5	T. Letterman	Vol #:	23

EXT 6	A. Hall	Vol #:	23

EXT 7	T. Letterman	Vol #:	23

EXT 8	M. Cheng	Vol #:	23

EXT 9	H. Hellberg	Vol #:	23

2004D-0193	Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)

GDL 2	Guidance	Vol #:	1

NAD 2	FDA	Vol #:	1

2006D-0480	Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration

NAD 1	FDA	Vol #:	1

2006N-0425	Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notification

N 2	FDA	Vol #:	1

2006P-0498	Use of symbols on the principal display panel that would communicate to consumers the healthfulness of foods

C 15	R. Cline	Vol #:	1

C 16	T. Babstreine	Vol #:	1

C 17	A. Faust	Vol #:	1

C 18	C. Colter	Vol #:	1

C 19	J. Rusten	Vol #:	1

C 20	S. Johnson	Vol #:	1

C 21	M. Bonville	Vol #:	1

C 22	P. Kunc	Vol #:	1

C 23	B. Tabeer	Vol #:	1

C 24	Intercon Distributing, Inc.	Vol #:	1

C 25	L. Granbery	Vol #:	1

C 26	J. King	Vol #:	1

C 27	N. Vagnini	Vol #:	1



C 28	M. Fabbro	Vol #:	1

C 29	B. DeCamp	Vol #:	1

C 30	J. Schmid	Vol #:	1

C 31	B. North	Vol #:	1

C 32	K. Weinrib	Vol #:	1

C 33	J. Venderly	Vol #:	1

C 34	D. Dufresne	Vol #:	1

C 35	M. HInson	Vol #:	1

C 36	H. Nickles	Vol #:	1

C 37	V. Kane	Vol #:	1

C 38	L. Chont	Vol #:	1

C 39	C. Womack	Vol #:	1

C 40	S. Bastien	Vol #:	1

C 41	L. & G. Zimmerman	Vol #:	1

C 42	W. Hubbell	Vol #:	1

C 43	M. Robinson	Vol #:	1

C 44	E. Lerner	Vol #:	1

C 45	D. & J. Hanson	Vol #:	1

C 46	S. Sinmasaki	Vol #:	1

C 47	L. & D. Olds	Vol #:	1

C 48	W. Coats	Vol #:	1

C 49	B. Benson	Vol #:	1

C 50	J. Imsande	Vol #:	1

C 51	A. Dillard	Vol #:	1

C 52	W. Knapp	Vol #:	1

C 53	T. Budnik	Vol #:	1

C 54	M. Honegger	Vol #:	1

C 55	J. Stern	Vol #:	1

C 56	L. Rose	Vol #:	1

C 57	S. Faillace	Vol #:	1

2007D-0021	Guidance for Industry; Advisory Committee Meetings: Preparation and Public Availability of Information Given to Advisory Committee Members

GDL 1	Guidance	Vol #:	1

NAD 1	FDA	Vol #:	1

2007N-0016	Sentinel Network To Promote Medical Product Safety

EAPE 267	Crowley, Jay	Vol #:	1



EAPE 268	Orr, Jessica	Vol #:	1

EAPE 269	Ming, Eileen	Vol #:	1

EAPE 270	Emmett, Andrew	Vol #:	1

EAPE 271	Morgus, Vincent	Vol #:	1

EAPE 272	Graham, David	Vol #:	1

2007N-0019	Medical Devices; Anesthesiology Devices; Oxygen Pressure Regulators and Oxygen Conserving Devices

BKG 1	Background Material	Vol #:	2

NPR 1	FDA	Vol #:	1

Page created on June 19, 2007 ue

FDA/Dockets Management